Ideal Age and Qualifications for Cadaveric Donors of Acellular Dermal Matrices (ADMs)
Cadaveric donors for acellular dermal matrices (ADMs) should be between 18 and 60 years of age with a BMI between 18 and 30 kg/m².
Donor Age Requirements
The age of cadaveric donors is a critical factor in determining the quality of acellular dermal matrices:
- Optimal age range: 18-60 years
- British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines specifically recommend this age range for tissue donors 1
- Donors older than 60 years show losses of certain bacterial phyla (Actinobacteria and Bifidobactericeae) that may affect tissue quality 1
- Younger donors (under 18) are typically excluded from donation protocols to ensure mature tissue development
Physical Qualifications for Donors
Beyond age, several physical parameters are important for optimal ADM quality:
BMI requirements: 18-30 kg/m² 1
- Ensures appropriate tissue composition and quality
- Avoids potential complications associated with extreme body compositions
Health screening requirements:
- Absence of infectious diseases
- No history of malignancy
- No systemic diseases that might affect tissue quality
- Negative screening for hepatitis B, hepatitis C, and HIV
Processing Considerations
The quality of ADMs depends significantly on processing techniques:
Decellularization process:
Tissue harvesting:
Clinical Applications and Considerations
ADMs have diverse applications in reconstructive procedures:
Common applications:
Key advantages:
Pitfalls and Caveats
When selecting and using ADMs, be aware of these important considerations:
Donor selection:
- Thorough screening is essential to prevent disease transmission
- Different decellularization processes significantly impact the final ADM properties 4
Clinical use:
Storage and handling:
- Proper storage conditions are essential to maintain ADM integrity
- Rehydration protocols vary between products and must be followed precisely
By adhering to these age and qualification guidelines for cadaveric donors, clinicians can optimize the quality and safety of acellular dermal matrices for reconstructive procedures, ultimately improving patient outcomes in terms of morbidity, mortality, and quality of life.